Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.

2013

Background To evaluate if plasma levels of midregional pro-adrenomedullin (MR-proADM) improve prediction of functional outcome in ischemic stroke.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

41

References

9

Citations